Directive 65 65 EEC

Results: 32



#Item
1 Better protecting the patients Be aware of the system

Better protecting the patients Be aware of the system

Add to Reading List

Source URL: www.pharmacovigilance2012.nl

Language: English - Date: 2011-11-29 08:04:15
2JUDGMENT OF THE COURT 9 April 2015 (Veterinary medicinal products – Supplementary protection certificate – Regulation (EEC) No – Concept of “first authorisation to place a product on the market” in t

JUDGMENT OF THE COURT 9 April 2015 (Veterinary medicinal products – Supplementary protection certificate – Regulation (EEC) No – Concept of “first authorisation to place a product on the market” in t

Add to Reading List

Source URL: www.eftacourt.int

Language: English - Date: 2015-04-09 05:16:30
3Medicinal products for human use

Medicinal products for human use

Add to Reading List

Source URL: www.europarl.europa.eu

Language: English - Date: 2015-04-01 15:07:10
4EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Health systems and products Medicinal products – authorisations, European Medicines Agency  PHARM 663

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Health systems and products Medicinal products – authorisations, European Medicines Agency PHARM 663

Add to Reading List

Source URL: ec.europa.eu

Language: English - Date: 2014-10-24 08:50:49
5BEST PRACTICE GUIDE FOR THE EXCHANGE OF REGULATORY AND ADMINISTRATIVE INFORMATION REGARDING ORPHAN MEDICINAL PRODUCTS BETWEEN THE EMEAEMA AND THE NATIONAL COMPETENT AUTHORITIES October 2003

BEST PRACTICE GUIDE FOR THE EXCHANGE OF REGULATORY AND ADMINISTRATIVE INFORMATION REGARDING ORPHAN MEDICINAL PRODUCTS BETWEEN THE EMEAEMA AND THE NATIONAL COMPETENT AUTHORITIES October 2003

Add to Reading List

Source URL: www.hma.eu

Language: English - Date: 2011-11-25 05:34:30
6BEST PRACTICE GUIDE FOR THE EXCHANGE OF REGULATORY AND ADMINISTRATIVE INFORMATION REGARDING ORPHAN MEDICINAL PRODUCTS BETWEEN THE EMA AND THE NATIONAL COMPETENT AUTHORITIES Doc. Ref.: CMDh[removed], Rev2

BEST PRACTICE GUIDE FOR THE EXCHANGE OF REGULATORY AND ADMINISTRATIVE INFORMATION REGARDING ORPHAN MEDICINAL PRODUCTS BETWEEN THE EMA AND THE NATIONAL COMPETENT AUTHORITIES Doc. Ref.: CMDh[removed], Rev2

Add to Reading List

Source URL: www.hma.eu

Language: English - Date: 2011-11-25 05:34:29
7Risk regulation at international, European and national level  The Registration and Authorisation of Homeopathic Medicinal Products in the EU and The Netherlands Author: Johan Hulshof

Risk regulation at international, European and national level The Registration and Authorisation of Homeopathic Medicinal Products in the EU and The Netherlands Author: Johan Hulshof

Add to Reading List

Source URL: www.riskregulation.org

Language: English - Date: 2008-01-18 08:02:01
8Risk regulation at international, European and national level  MARKETING OF MEDICINAL PRODUCTS IN EUROPE: THE ABRIDGED PROCEDURE FOR MARKETING AUTHORISATION AUTHOR: Janske van Santvoort

Risk regulation at international, European and national level MARKETING OF MEDICINAL PRODUCTS IN EUROPE: THE ABRIDGED PROCEDURE FOR MARKETING AUTHORISATION AUTHOR: Janske van Santvoort

Add to Reading List

Source URL: www.riskregulation.org

Language: English - Date: 2008-01-17 11:13:05
9COMMISSION REGULATION (EC) No …/… of […] laying down the provisions for implementation of the criteria for designation of a medicinal product as an orphan medicinal product and definitions of the concepts “simila

COMMISSION REGULATION (EC) No …/… of […] laying down the provisions for implementation of the criteria for designation of a medicinal product as an orphan medicinal product and definitions of the concepts “simila

Add to Reading List

Source URL: ec.europa.eu

Language: English - Date: 2014-11-12 03:09:45
10AESGP WELCOMES NEW CPMP OFFICERS AND MEMBERS

AESGP WELCOMES NEW CPMP OFFICERS AND MEMBERS

Add to Reading List

Source URL: www.aesgp.eu

Language: English